Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and pheripherally acting 5HT1B/1D agonist : international clinical experience based on >3000 subjects treated with zolmitriptan
John G. Edmeads
Artikkel Engelsk
Logg inn for flere valg